BTC $64,699.37 +0.45%
ETH $1,917.55 +0.78%
BNB $586.72 +3.07%
XRP $1.08 +1.01%
SOL $74.41 +1.22%
TRX $0.3278 +0.49%
DOGE $0.0703 -0.26%
ADA $0.1681 +2.48%
BCH $219.07 +4.05%
LINK $8.48 +1.82%
HYPE $53.63 -2.81%
AAVE $99.46 +0.78%
SUI $0.6959 +1.26%
XLM $0.1727 -0.39%
ZEC $474.12 +1.82%
BTC $64,699.37 +0.45%
ETH $1,917.55 +0.78%
BNB $586.72 +3.07%
XRP $1.08 +1.01%
SOL $74.41 +1.22%
TRX $0.3278 +0.49%
DOGE $0.0703 -0.26%
ADA $0.1681 +2.48%
BCH $219.07 +4.05%
LINK $8.48 +1.82%
HYPE $53.63 -2.81%
AAVE $99.46 +0.78%
SUI $0.6959 +1.26%
XLM $0.1727 -0.39%
ZEC $474.12 +1.82%

The publicly traded company Applied DNA Sciences disclosed that its initial BNB holdings are valued at over 17 million dollars

2025-10-22 20:20:58
Collection

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has completed the previously announced private equity investment (PIPE) financing led by institutional DeFi and TradFi investors, with an initial BNB holding valued at over $17 million.

The PIPE brought the company approximately $27 million in total proceeds, with the potential to gain an additional total of up to $31 million in the future through the exercise of warrants. The total proceeds from the PIPE transaction include $15.3 million in cash and stablecoins, as well as $11.71 million in OBNB trust units.

The company has received a total of 435,638 trust units, which represent underlying ownership of 10,647 BNB tokens. The company also announced today that it has additionally purchased 4,908 BNB tokens, estimated to be worth $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.

app_icon
ChainCatcher Building the Web3 world with innovations.